Inventor
CHAEMIN LIM
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
A61KPreparations for medical, dental or toiletry purposes9%
G06FElectric digital data processing9%
G11CStatic stores9%
H10WGeneric packages, interconnections, connectors or other constructional details of devices covered by class h109%
Y02DClimate change mitigation technologies in information and communication technologies [ict], i.e. information and communication technologies aiming at the reduction of their own energy use9%
Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to UNIV CALIFORNIA (2)· patent assignee history
2022–2026Patents assigned to UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (2)· patent assignee history
2022Patents assigned to NAT INSTITUTES OF HEALTH A COMPONENT OF THE U S DEPARTMENT OF HEARTH AND HUMAN SERVICES (1)· patent assignee history
2022Patents assigned to NAT INSTITUTES OF HEALTH A COMPONENT OF THE UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES (1)· patent assignee history
2022–2026Based in US· patent location history
2024Patents assigned to A2A PHARMACEUTICALS INC (1)· patent assignee history
2025Based in KR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV CALIFORNIA | 2 | 2022–2026 |
| UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2 | 2022–2026 |
| A2A PHARMACEUTICALS INC | 1 | 2024 |
| NAT INSTITUTES OF HEALTH A COMPONENT OF THE U S DEPARTMENT OF HEARTH AND HUMAN SERVICES | 1 | 2022 |
| NAT INSTITUTES OF HEALTH A COMPONENT OF THE UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 3 | 2022–2026 |
| KR | 1 | 2025 |